Abstract: The present invention provides the use of the antigens CD49e and/or CD49f as selection markers for enrichment, isolation, detection and/or analysis of atrial and ventricular cardiomyocytes and a method for enrichment, isolation, detection and/or analysis of these cells from a sample comprising cardiomyocytes. In addition substantially pure compositions of these cardiomyocyte subpopulations are provided.
Type:
Grant
Filed:
November 19, 2014
Date of Patent:
August 1, 2017
Assignee:
Miltenyi Biotec
Inventors:
Anne Maria Wiencierz, Dominik Eckardt, Andreas Bosio